Literature DB >> 26439896

Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Yongxian Hu1, Qu Cui1,2, Yishan Ye1, Yi Luo1, Yamin Tan1, Jimin Shi1, He Huang1.   

Abstract

Foxp3+ T cells (CD4+ Tregs and CD8+ Treg) have been demonstrated to play roles in the maintenance of tolerance after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). We have found that Foxp3+ γδTCR+ Treg cells (γδTregs) exerted regulatory functions. In the current study, patients were recruited and divided as non-cGVHD, limited cGVHD and extensive cGVHD groups. Healthy volunteers were recruited as healthy group. Treg cells were evaluated by flow cytometry. Serum cytokine levels of IL-2, tumour necrosis factor-α, interferon-γ and transforming growth factor-β1 (TGF-β1) were evaluated by ELISA. The results showed that percentages of CD4+ Tregs, CD8+ Tregs and γδTregs were all significantly increased in non-cGVHD group compared with those in healthy group, limited cGVHD group and extensive cGVHD group. Moreover, compared with extensive cGVHD group, percentages of these three types of Tregs were significantly increased in limited cGVHD group. The levels of TGF-β1 increased dramatically in non-cGVHD group compared with other groups. Spearman's correlation analysis revealed that the increased levels of TGF-β1 and IL-2 were positively associated with increased Treg subsets, indicating that TGF-β1 and IL-2 participated in the expansion process of Foxp3+ Tregs in vivo. Our findings support that increasing the number of Tregs following allo-HSCT would be a preferential strategy for controlling cGVHD.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  chronic graft-versus-host disease; hematopoietic stem cell transplantation; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26439896     DOI: 10.1002/hon.2255

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  7 in total

1.  Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.

Authors:  Lucas C M Arruda; Ahmed Gaballa; Michael Uhlin
Journal:  Blood Adv       Date:  2019-11-12

2.  Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation.

Authors:  Oliver McCallion; Joanna Hester; Fadi Issa
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

Review 3.  An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Hana Andrlová; Marcel R M van den Brink; Kate A Markey
Journal:  Front Oncol       Date:  2021-02-18       Impact factor: 6.244

4.  Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.

Authors:  Li Xuan; Xiuli Wu; Dan Qiu; Li Gao; Hui Liu; Zhiping Fan; Fen Huang; Zhenyi Jin; Jing Sun; Yangqiu Li; Qifa Liu
Journal:  J Transl Med       Date:  2018-05-25       Impact factor: 5.531

5.  [Advances in the pathogenesis of chronic graft versus host disease].

Authors:  Q Q Wang; R L Zhang; M Z Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-02-14

Review 6.  The Roles of γδ T Cells in Hematopoietic Stem Cell Transplantation.

Authors:  Wanyi Ye; Xueting Kong; Wenbin Zhang; Zheng Weng; Xiuli Wu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 7.  A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives.

Authors:  Zhongyu Han; Kuai Ma; Hongxia Tao; Hongli Liu; Jiong Zhang; Xiyalatu Sai; Yunlong Li; Mingxuan Chi; Qing Nian; Linjiang Song; Chi Liu
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.